Chargement en cours...
Lichenoid drug eruption due to imatinib mesylate
Imatinib mesylate is a selective tyrosinase kinase inhibitor which has revolutionized the treatment of chronic myeloid leukemia. It is also used in gastrointestinal stromal tumors and dermatofibrosarcoma protruberans. Cutaneous adverse reactions are the most common nonhematological side effects seco...
Enregistré dans:
| Publié dans: | Int J Appl Basic Med Res |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318107/ https://ncbi.nlm.nih.gov/pubmed/25664274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-516X.149253 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|